H-Gln-AMC

H-Gln-AMC is an N-acetylated glutamine derivative in which the side-chain amide of the Gln residue is retained while the α-amino group is capped (H-Gln-AMC indicates an N-protected amino acid precursor) and the C-terminus is linked to 7-amino-4-methylcoumarin (AMC) through an amide-forming handle. The molecule therefore combines a stereodefined glutamine backbone with a fluorescent coumarin reporter, enabling sensitive readout of enzymatic or chemical cleavage events. The glutamine side chain provides a polar hydrogen-bonding motif that can participate in substrate recognition, while the AMC fluorophore introduces strong optical properties suitable for quantitative monitoring. The overall structure functions as a research-grade amino acid-fluorogenic conjugate and can be used as a downstream intermediate for peptide-like substrates and analytical reagents.

1. Fluorogenic Protease Substrates

H-Gln-AMC is applied in biochemical assay development for fluorogenic protease and peptidase substrate screening, where the AMC moiety serves as a cleavage-dependent fluorescence reporter. The glutamine-derived side-chain amide and the defined amino acid connectivity can mimic recognition features of Gln-containing peptide substrates, supporting enzyme-dependent turnover rather than purely nonspecific hydrolysis. The N-capped amino acid framework and the amide linkage to AMC facilitate stable handling during assay setup and allow the cleavage event to translate into a measurable signal. H-Gln-AMC can be employed to generate substrate panels for protease specificity profiling and to support structure-informed selection of peptide coupling motifs in amino acid chemistry.

2. Peptide Coupling Chemistry

H-Gln-AMC is suitable for peptide synthesis compatibility studies and for designing glutamine-containing peptide building blocks that incorporate a coumarin reporter at the C-terminus. The protected glutamine amino functionality and the amide-bearing AMC acceptor enable coupling logic that aligns with standard peptide bond formation strategies, including approaches that preserve side-chain integrity. The retained side-chain amide of the glutamine residue can be leveraged for controlled derivatization or for maintaining native-like polarity in peptide analogs. H-Gln-AMC thus serves as a practical intermediate concept for constructing fluorescent peptide substrates and for evaluating coupling chemistries that tolerate polar amino acid side chains.

3. Chemical Biology Assays

H-Gln-AMC functions in chemical biology research as a fluorescent readout reagent for studying enzyme kinetics, inhibitor effects, and substrate recognition in Gln-dependent contexts. The AMC fluorophore provides an optical handle for real-time or endpoint monitoring, while the glutamine backbone features a side-chain amide that can participate in binding interactions and orient the scissile bond. The N-acylated amino acid derivative form helps define the chemical environment around the cleavage site, supporting reproducible assay behavior across experimental series. H-Gln-AMC can be applied to generate quantitative datasets used to refine biochemical hypotheses about amino acid sequence effects and to guide subsequent peptide analog design.

4. Analytical Research Standards

H-Gln-AMC is used in analytical research for method development and calibration of fluorescence-based detection workflows involving amino acid-coumarin conjugates. The stable coumarin reporter enables consistent excitation/emission behavior, while the glutamine-derived portion provides a chemically defined motif for verifying specificity in assay matrices. The amide linkage architecture supports reproducible signal generation upon cleavage, enabling use as a reference substrate for validating assay performance and for comparing relative reactivity among related amino acid derivatives. H-Gln-AMC can also serve as a biochemical research intermediate when preparing related AMC-tagged amino acid substrates for chromatographic or fluorescence detection studies.

5. Peptidomimetic Probe Design

H-Gln-AMC can be employed in peptidomimetic probe design where a glutamine-like polar side chain is coupled to a fluorescent reporter to interrogate binding and cleavage behavior. The side-chain amide functionality provides a handle for mimicking hydrogen-bonding patterns common to Gln-containing motifs, while the AMC reporter enables readout of probe engagement through fluorescence changes tied to bond scission. The N-protected amino acid character supports controlled synthesis of probe analogs and helps maintain a defined stereochemical relationship between backbone and reporter. H-Gln-AMC thereby supports downstream generation of structure-activity relationship tool compounds that connect amino acid derivatization with measurable chemical biology outcomes.

6. Process Chemistry Intermediate

H-Gln-AMC is relevant to process chemistry and specialty chemical production as a defined amino acid-fluorophore conjugate intermediate for manufacturing fluorescent substrate reagents. The molecule's functional group set, including the polar glutamine side-chain amide and the robust AMC amide linkage, can be leveraged to design scalable synthetic routes that maintain reporter integrity through protection and coupling steps. The N-acylated amino acid framework can support purification strategies based on predictable polarity and can reduce undesired side reactions during intermediate handling. H-Gln-AMC can be utilized to prepare reagent families used in industrial biochemical testing workflows and to support consistent production of AMC-tagged amino acid derivatives for ongoing assay development.

1. C-peptide and its C-terminal fragments improve erythrocyte deformability in type 1 diabetes patients

2. Odorant binding protein based biomimetic sensors for detection of alcohols associated with Salmonella contamination in packaged beef

3. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die

4. P-selectin and Complement’s Role in a Neonatal Model of Germinal Matrix Hemorrhage-Induced Secondary Injury

5. Investigating Potential Interactions Between Neurohypophyseal Peptides, their Drug Analogs, and Coagulation Factor VIII